Dexcom (DXCM) Treasury Shares (2011 - 2026)

Dexcom (DXCM) has 9 years of Treasury Shares data on file, last reported at $2.1 billion in Q1 2026.

• Quarterly Treasury Shares rose 34.11% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 34.11% YoY) and the FY2025 annual result came in at $2.1 billion, up 31.85% from the prior year.
• Treasury Shares climbed to $2.1 billion in Q1 2026 per DXCM's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $26.4 million in Q1 2026 and bottomed at $100000.0 in Q1 2022.
• The 5-year median for Treasury Shares is $7.8 million (2024), against an average of $10.5 million.
• The widest annual swing landed in 2022, when Treasury Shares sank 62.7%; it then jumped 2002.14% in 2023.
• Tracing DXCM's Treasury Shares over 5 years: stood at $595.0 million in 2022, then jumped by 311.95% to $2.5 billion in 2023, then plunged by 35.49% to $1.6 billion in 2024, then surged by 31.85% to $2.1 billion in 2025, then advanced by 1.72% to $2.1 billion in 2026.
• Per Business Quant, the three latest DXCM Treasury Shares figures stand at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $1.8 billion (Q3 2025).

Peer Comparison